Annals of Oncology

in this issue:

in this issue
Ann Oncol 18: 811; doi:10.1093/annonc/mdm131
[Extract] [Full Text] [PDF] [Request Permissions]

editorial:

A Di Leo

The state of HER-2 status
Ann Oncol 18: 813-815; doi:10.1093/annonc/mdm179
[Extract] [Full Text] [PDF] [Request Permissions]

reviews:

N Blijlevens and S Sonis

Palifermin (recombinant keratinocyte growth factor-1): a pleiotropic growth factor with multiple biological activities in preventing chemotherapy- and radiotherapy-induced mucositis
Annals of Oncology Advance Access published on October 9, 2006
Ann Oncol 18: 817-826; doi:10.1093/annonc/mdl332
[Abstract] [Full Text] [PDF] [Request Permissions]

TD Yan, L Welch, D Black, and PH Sugarbaker

A systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for diffuse malignancy peritoneal mesothelioma
Annals of Oncology Advance Access published on November 27, 2006
Ann Oncol 18: 827-834; doi:10.1093/annonc/mdl428
[Abstract] [Full Text] [PDF] [Request Permissions]

FGE Perabo and SC Müller

New agents for treatment of advanced transitional cell carcinoma
Annals of Oncology Advance Access published on October 3, 2006
Ann Oncol 18: 835-843; doi:10.1093/annonc/mdl331
[Abstract] [Full Text] [PDF] [Request Permissions]

original articles:

breast cancer:

J Bergqvist, JF Ohd, J Smeds, S Klaar, J Isola, H Nordgren, GP Elmberger, H Hellborg, J Bjohle, A-L Borg, L Skoog, and J Bergh

Quantitative real-time PCR analysis and microarray-based RNA expression of HER2 in relation to outcome
Annals of Oncology Advance Access published on March 9, 2007
Ann Oncol 18: 845-850; doi:10.1093/annonc/mdm059
[Abstract] [Full Text] [PDF] [Request Permissions]

S Apostolaki, M Perraki, A Pallis, V Bozionelou, S Agelaki, P Kanellou, A Kotsakis, E Politaki, K Kalbakis, A Kalykaki, L Vamvakas, V Georgoulias, and D Mavroudis

Circulating HER2 mRNA-positive cells in the peripheral blood of patients with stage I and II breast cancer after the administration of adjuvant chemotherapy: evaluation of their clinical relevance
Annals of Oncology Advance Access published on February 14, 2007
Ann Oncol 18: 851-858; doi:10.1093/annonc/mdl502
[Abstract] [Full Text] [PDF] [Request Permissions]

L Mauriac, A Keshaviah, M Debled, H Mouridsen, JF Forbes, B Thürlimann, R Paridaens, A Monnier, I Láng, A Wardley, J-M Nogaret, RD Gelber, M Castiglione-Gertsch, KN Price, AS Coates, I Smith, G Viale, M Rabaglio, N Zabaznyi, and A Goldhirsch On the behalf of BIG 1-98 Collaborative Group and International Breast Cancer Study Group, Berne, Switzerland

Predictors of early relapse in postmenopausal women with hormone receptor-positive breast cancer in the BIG 1-98 trial
Annals of Oncology Advance Access published on February 14, 2007
Ann Oncol 18: 859-867; doi:10.1093/annonc/mdm001
[Abstract] [Full Text] [PDF] [Request Permissions]

C Chapman, A Murray, J Chakrabarti, A Thorpe, C Woolston, U Sahin, A Barnes, and J Robertson

Autoantibodies in breast cancer: their use as an aid to early diagnosis
Annals of Oncology Advance Access published on March 7, 2007
Ann Oncol 18: 868-873; doi:10.1093/annonc/mdm007
[Abstract] [Full Text] [PDF] [Request Permissions]

C Mazouni, S-W Kau, D Frye, F Andre, HM Kuerer, TA Buchholz, WF Symmans, K Anderson, KR Hess, AM Gonzalez-Angulo, GN Hortobagyi, AU Buzdar, and L Pusztai

Inclusion of taxanes, particularly weekly paclitaxel, in preoperative chemotherapy improves pathologic complete response rate in estrogen receptor-positive breast cancers
Annals of Oncology Advance Access published on February 10, 2007
Ann Oncol 18: 874-880; doi:10.1093/annonc/mdm008
[Abstract] [Full Text] [PDF] [Request Permissions]

gynecologic tumors:

JM Riedinger, F Bonnetain, JP Basuyau, N Eche, H Larbre, I Dalifard, J Wafflart, G Ricolleau, and MF Pichon

Change in CA 125 levels after the first cycle of induction chemotherapy is an independent predictor of epithelial ovarian tumour outcome
Annals of Oncology Advance Access published on February 13, 2007
Ann Oncol 18: 881-885; doi:10.1093/annonc/mdl500
[Abstract] [Full Text] [PDF] [Request Permissions]

gastrointestinal tumors:

J Lee, T Lim, JE Uhm, KW Park, SH Park, SC Lee, JO Park, YS Park, HY Lim, TS Sohn, JH Noh, JS Heo, CK Park, S Kim, and WK Kang

Prognostic model to predict survival following first-line chemotherapy in patients with metastatic gastric adenocarcinoma
Annals of Oncology Advance Access published on February 13, 2007
Ann Oncol 18: 886-891; doi:10.1093/annonc/mdl501
[Abstract] [Full Text] [PDF] [Request Permissions]

HJ Kim, TW Yoo, DI Park, JH Park, YK Cho, CI Sohn, WK Jeon, BI Kim, MK Kim, SW Chae, and JH Sohn

Gene amplification and protein overexpression of HER-2/neu in human extrahepatic cholangiocarcinoma as detected by chromogenic in situ hybridization and immunohistochemistry: its prognostic implication in node-positive patients
Annals of Oncology Advance Access published on February 23, 2007
Ann Oncol 18: 892-897; doi:10.1093/annonc/mdm006
[Abstract] [Full Text] [PDF] [Request Permissions]

DH Ilson, RG Wadleigh, LP Leichman, and DP Kelsen

Paclitaxel given by a weekly 1-h infusion in advanced esophageal cancer
Annals of Oncology Advance Access published on March 9, 2007
Ann Oncol 18: 898-902; doi:10.1093/annonc/mdm004
[Abstract] [Full Text] [PDF] [Request Permissions]

lung cancer:

S Novello, P Bruzzi, C Barone, R Buosi, A Masotti, G Michetti, M Fioretti, S Barbera, M Spatafora, L Garetto, P Mazzanti, V Dongiovanni, G Selvaggi, L Crinò, and GV Scagliotti

Phase III study in stage IV non-small-cell lung cancer patients treated with two courses of cisplatin/gemcitabine followed by a randomization to three additional courses of the same combination or gemcitabine alone
Annals of Oncology Advance Access published on March 9, 2007
Ann Oncol 18: 903-908; doi:10.1093/annonc/mdm061
[Abstract] [Full Text] [PDF] [Request Permissions]

D De Ruysscher, C Dehing, R-H Bremer, SM Bentzen, F Koppe, M Pijls-Johannesma, L Harzée, A Minken, R Wanders, M Hochstenbag, A-M Dingemans, L Boersma, E van Haren, W Geraedts, C Pitz, J Simons, BG Wouters, J-F Rosier, and P Lambin

Maximal neutropenia during chemotherapy and radiotherapy is significantly associated with the development of acute radiation-induced dysphagia in lung cancer patients
Annals of Oncology Advance Access published on February 23, 2007
Ann Oncol 18: 909-916; doi:10.1093/annonc/mdm005
[Abstract] [Full Text] [PDF] [Request Permissions]

urogenital tumors:

S Culine, P Kerbrat, A Kramar, C Théodore, C Chevreau, L Geoffrois, NB Bui, J Pény, A Caty, R Delva, P Biron, K Fizazi, J Bouzy, and JP Droz

Refining the optimal chemotherapy regimen for good-risk metastatic nonseminomatous germ-cell tumors: a randomized trial of the Genito-Urinary Group of the French Federation of Cancer Centers (GETUG T93BP)
Annals of Oncology Advance Access published on March 9, 2007
Ann Oncol 18: 917-924; doi:10.1093/annonc/mdm062
[Abstract] [Full Text] [PDF] [Request Permissions]

J Shamash, T Powles, K Mutsvangwa, P Wilson, W Ansell, E Walsh, D Berney, J Stebbing, and T Oliver

A phase II study using a topoisomerase I-based approach in patients with multiply relapsed germ-cell tumours
Annals of Oncology Advance Access published on March 12, 2007
Ann Oncol 18: 925-930; doi:10.1093/annonc/mdm002
[Abstract] [Full Text] [PDF] [Request Permissions]

hematologic malignancies:

H Veelken, S Vik Dannheim, J Schulte Moenting, UM Martens, J Finke, and A Schmitt-Graeff

Immunophenotype as prognostic factor for diffuse large B-cell lymphoma in patients undergoing clinical risk-adapted therapy
Annals of Oncology Advance Access published on March 29, 2007
Ann Oncol 18: 931-939; doi:10.1093/annonc/mdm012
[Abstract] [Full Text] [PDF] [Request Permissions]

quality of life:

PC Dagnelie, MCG Pijls-Johannesma, P Lambin, S Beijer, D De Ruysscher, and GIJM Kempen

Impact of fatigue on overall quality of life in lung and breast cancer patients selected for high-dose radiotherapy
Annals of Oncology Advance Access published on March 15, 2007
Ann Oncol 18: 940-944; doi:10.1093/annonc/mdm057
[Abstract] [Full Text] [PDF] [Request Permissions]

palliative care:

AA Ayantunde and SL Parsons

Pattern and prognostic factors in patients with malignant ascites: a retrospective study
Annals of Oncology Advance Access published on February 13, 2007
Ann Oncol 18: 945-949; doi:10.1093/annonc/mdl499
[Abstract] [Full Text] [PDF] [Request Permissions]

supportive care:

M Kleber, M Cybulla, K Bauchmüller, G Ihorst, B Koch, and M Engelhardt

Monitoring of renal function in cancer patients: an ongoing challenge for clinical practice
Annals of Oncology Advance Access published on March 9, 2007
Ann Oncol 18: 950-958; doi:10.1093/annonc/mdm055
[Abstract] [Full Text] [PDF] [Request Permissions]

letters to the editor:

P Tassone, P Tagliaferri, I Cucinotto, AM Lavecchia, F Leone, A Pietragalla, A Salvino, V Barbieri, and S Venuta

Liposomal doxorubicin is active in Stewart–Treves syndrome
Ann Oncol 18: 959-960; doi:10.1093/annonc/mdm113
[Extract] [Full Text] [PDF] [Request Permissions]

A Ottaiano, A Budillon, N Normanno, VR Iaffaioli, and M Caraglia

A multidisciplinary approach is required to increase the quality of phase II/III clinical studies on biotherapies in oncology
Annals of Oncology Advance Access published on April 16, 2007
Ann Oncol 18: 960-961; doi:10.1093/annonc/mdm115
[Extract] [Full Text] [PDF] [Request Permissions]

P Specenier, C Koppen, and JB Vermorken

Diffuse punctate keratitis in a patient treated with cetuximab as monotherapy
Annals of Oncology Advance Access published on April 17, 2007
Ann Oncol 18: 961-962; doi:10.1093/annonc/mdm116
[Extract] [Full Text] [PDF] [Request Permissions]

MV Karamouzis, PA Konstantinopoulos, and AG Papavassiliou

Intriguing issues of EGFR targeting in head and neck cancer
Annals of Oncology Advance Access published on April 17, 2007
Ann Oncol 18: 962; doi:10.1093/annonc/mdm117
[Extract] [Full Text] [PDF] [Request Permissions]

M Mego, M Recková, Z Sycova-Mila, J Obertova, K Brozmanova, T Salek, and J Mardiak

Bevacizumab in a growing teratoma syndrome. Case report
Annals of Oncology Advance Access published on April 13, 2007
Ann Oncol 18: 962-963; doi:10.1093/annonc/mdm125
[Extract] [Full Text] [PDF] [Request Permissions]

D Helbling and M Borner

Successful challenge with the fully human EGFR antibody panitumumab following an infusion reaction with the chimeric EGFR antibody cetuximab
Ann Oncol 18: 963-964; doi:10.1093/annonc/mdm130
[Extract] [Full Text] [PDF] [Request Permissions]

Y Wang, GB Kristensen, A-L Børresen-Dale, and Å Helland

TP53 mutations and codon 72 genotype—impact on survival among ovarian cancer patients
Ann Oncol 18: 964-966; doi:10.1093/annonc/mdm134
[Extract] [Full Text] [PDF] [Request Permissions]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.